Nolan A Wages

20PUBLICATIONS
35CO-AUTHORS
Radiation therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 30, 2026
Phase I design for partially ordered groups with late-onset toxicity.

|Jan 23, 2026
International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR.

Emily Alger, Olalekan Lee Aiyegbusi, Amylou C Dueck

|Mar 28, 2025
Design of a Phase I Drug Combination Study with Adaptive Allocation Based on Dose-Limiting Toxicity Attribution.

Nolan A Wages, Bethany J Horton, Li Liu

|Mar 26, 2025
Understanding the Role of Patient-Reported Outcomes for Decision-Making in Early-Phase Dose-Finding Clinical Trials.

Richard Brown, Nolan A Wages, Li Liu

|Apr 04, 2024
Current issues in dose-finding designs: A response to the US Food and Drug Adminstration's Oncology Center of Excellence Project Optimus.

Peter F Thall, Elizabeth Garrett-Mayer, Nolan A Wages

|Mar 30, 2024
Applications of the partial-order continual reassessment method in the early development of treatment combinations.

Nolan A Wages, Patrick M Dillon, Craig A Portell

Pageof 4

Frequent Collaborators

2 joint publications

David Schiff

2 joint publications

Susan Halabi

1 joint publications

Craig A Portell

1 joint publications

Brad S Kahl